How Pharmaceutical Companies Are Using Intelligence Reporting to Track Supply Chain Risk

Most pharmaceutical supply chain teams find out about sourcing problems the same way everyone else does — through a news alert or a supplier email that arrives after the disruption has already started. This post breaks down what proactive pharma supply chain intelligence actually looks like: how to monitor API sourcing risk in sanctioned regions, what DSCSA enforcement means operationally in 2025–2026, how tariff volatility is reshaping network design decisions, and where AI-powered predictive alerting adds genuine value.